UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Photodynamic Therapy Plus Chemotherapy Compared with Photodynamic Therapy Alone in Hilar Nonresectable Cholangiocarcinoma

Gut and Liver, 2016, 10(3), , pp.470-475

2016

Volltextzugriff (PDF)

Inflammation-driven malnutrition: a new screening tool predicts outcome in Crohn’s disease

British journal of nutrition, 2016-09, Vol.116 (6), p.1061-1067

2016

Volltextzugriff (PDF)

Pyostomatitis vegetans Zahlreiche blassgelbe Punkte auf entzündlich rotem Grund: Ein Fallbericht

Swiss dental journal, 2017-06, Vol.127 (6), p.523-530

2017

Volltextzugriff (PDF)

Diagnostic delay in inflammatory bowel diseases in a German population

World journal of gastroenterology : WJG, 2024-08, Vol.30 (29), p.3465-3478

2024

Volltextzugriff (PDF)

Genes involved in the regulation of intestinal permeability and their role in ulcerative colitis

Journal of digestive diseases, 2015-12, Vol.16 (12), p.713-722

2015

Volltextzugriff (PDF)

Increased small intestinal permeability in ulcerative colitis: Rather genetic than environmental and a risk factor for extensive disease?

Inflammatory bowel diseases, 2012-10, Vol.18 (10), p.1932-1939

2012

Volltextzugriff (PDF)

A Promoter Variant Within the Aryl Hydrocarbon Receptor Gene Is Associated with an Epithelial Barrier Defect in Smokers with Crohn's Disease

Inflammatory bowel diseases, 2016-10, Vol.22 (10), p.2356-2368

2016

Volltextzugriff (PDF)

PTGER4 modulating variants in Crohn’s disease

International journal of colorectal disease, 2014-08, Vol.29 (8), p.909-915

2014

Volltextzugriff (PDF)

Pyostomatite végétante Nombreux points jaune pâle sur fond rouge inflammatoire: Présentation d’un cas clinique

Swiss dental journal, 2017-06, Vol.127 (6), p.531-537

2017

Volltextzugriff (PDF)

The JAK2 variant rs10758669 in Crohn’s disease: altering the intestinal barrier as one mechanism of action

International journal of colorectal disease, 2012-05, Vol.27 (5), p.565-573

2012

Volltextzugriff (PDF)

Pyostomatitis vegetans. Numerous pale yellow dots on inflammatory red ground - A case report.

Swiss dental journal, 2017, Vol.127 (6), p.523

2017

Volltextzugriff (PDF)

Importance of rare and private NOD2 variants in foreseeing severe disease behavior in Crohn's disease

The American journal of gastroenterology, 2011-11, Vol.106 (11), p.2044-2045

2011

Volltextzugriff (PDF)

Colonic expression of the peptide transporter PEPT1 is downregulated during intestinal inflammation and is not required for NOD2-dependent immune activation

Inflammatory bowel diseases, 2014-04, Vol.20 (4), p.671-684

2014

Volltextzugriff (PDF)

Photodynamic Therapy Plus Chemotherapy Compared with Photodynamic Therapy Alone in Hilar Nonresectable Cholangiocarcinoma

Gut and liver, 2016-03, Vol.10 (3), p.470

2016

Volltextzugriff (PDF)

Photodynamic Therapy Plus Chemotherapy Compared with Photodynamic Therapy Alone in Hilar Nonresectable Cholangiocarcinoma

Gut and liver, 2016-03, Vol.10 (3), p.470

2016

Volltextzugriff (PDF)

Photodynamic Therapy Plus Chemotherapy Compared with Photodynamic Therapy Alone in Hilar Nonresectable Cholangiocarcinoma

Gut and liver, 2016-03, Vol.10 (3), p.470

2016

Volltextzugriff (PDF)

Photodynamic Therapy Plus Chemotherapy Compared with Photodynamic Therapy Alone in Hilar Nonresectable Cholangiocarcinoma

Gut and liver, 2016-03, Vol.10 (3), p.470

2016

Volltextzugriff (PDF)

Myosin IXb variants and their pivotal role in maintaining the intestinal barrier: A study in Crohn's disease

Scandinavian journal of gastroenterology, 2014-10, Vol.49 (10), p.1191-1200

2014

Volltextzugriff (PDF)

Mo1334 Reasons for the Delay of Diagnosis in Inflammatory Bowel Disease

Gastroenterology (New York, N.Y. 1943), 2013-05, Vol.144 (5), p.S-639-S-640

2013

Volltextzugriff (PDF)

W1218 Influence of the JAK2 Variant Rs10758669 on Crohn's Disease: Altering the Intestinal Barrier as One Mechanism of Action

Gastroenterology (New York, N.Y. 1943), 2010, Vol.138 (5), p.S-676-S-676

2010

Volltextzugriff (PDF)

Prevalence of cardiac beta-myosin heavy chain gene mutations in patients with hypertrophic cardiomyopathy

Journal of molecular medicine (Berlin, Germany), 2005-06, Vol.83 (6), p.468-477

2005

Volltextzugriff (PDF)

Prevalence of cardiac beta-myosin heavy chain gene mutations in patients with hypertrophic cardiomyopathy

Journal of molecular medicine (Berlin, Germany), 2005-10, Vol.83 (10), p.837-837

2005

Volltextzugriff (PDF)

Genes involved in the regulation of intestinal permeability and their role in ulcerative colitis

Journal of Digestive Diseases, 2015, Vol.16 (12), p.713-722

2015

Volltextzugriff (PDF)

Integrins in the Spotlight of Cancer

International journal of molecular sciences, 2016-12, Vol.17 (12), p.2037-2037

2016

Volltextzugriff (PDF)

A real-world analysis of second-line treatment options in pancreatic cancer: liposomal-irinotecan plus 5-fluorouracil and folinic acid

Therapeutic advances in medical oncology, 2019-07, Vol.11, p.1758835919853196-1758835919853196

2019

Volltextzugriff (PDF)

1 – 25 von 169

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(156)
Mit Volltextzugriff
(155)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Photodynamic Therapy Plus Chemotherapy Compared with Photodynamic Therapy Alone in Hilar Nonresectable Cholangiocarcinoma

Inflammation-driven malnutrition: a new screening tool predicts outcome in Crohn’s disease

Pyostomatitis vegetans Zahlreiche blassgelbe Punkte auf entzündlich rotem Grund: Ein Fallbericht

Diagnostic delay in inflammatory bowel diseases in a German population

Genes involved in the regulation of intestinal permeability and their role in ulcerative colitis

Increased small intestinal permeability in ulcerative colitis: Rather genetic than environmental and a risk factor for extensive disease?

A Promoter Variant Within the Aryl Hydrocarbon Receptor Gene Is Associated with an Epithelial Barrier Defect in Smokers with Crohn's Disease

PTGER4 modulating variants in Crohn’s disease

Pyostomatite végétante Nombreux points jaune pâle sur fond rouge inflammatoire: Présentation d’un cas clinique

The JAK2 variant rs10758669 in Crohn’s disease: altering the intestinal barrier as one mechanism of action

Pyostomatitis vegetans. Numerous pale yellow dots on inflammatory red ground - A case report.

Importance of rare and private NOD2 variants in foreseeing severe disease behavior in Crohn's disease

Colonic expression of the peptide transporter PEPT1 is downregulated during intestinal inflammation and is not required for NOD2-dependent immune activation

Photodynamic Therapy Plus Chemotherapy Compared with Photodynamic Therapy Alone in Hilar Nonresectable Cholangiocarcinoma

Photodynamic Therapy Plus Chemotherapy Compared with Photodynamic Therapy Alone in Hilar Nonresectable Cholangiocarcinoma

Photodynamic Therapy Plus Chemotherapy Compared with Photodynamic Therapy Alone in Hilar Nonresectable Cholangiocarcinoma

Photodynamic Therapy Plus Chemotherapy Compared with Photodynamic Therapy Alone in Hilar Nonresectable Cholangiocarcinoma

Myosin IXb variants and their pivotal role in maintaining the intestinal barrier: A study in Crohn's disease

Mo1334 Reasons for the Delay of Diagnosis in Inflammatory Bowel Disease

W1218 Influence of the JAK2 Variant Rs10758669 on Crohn's Disease: Altering the Intestinal Barrier as One Mechanism of Action

Prevalence of cardiac beta-myosin heavy chain gene mutations in patients with hypertrophic cardiomyopathy

Prevalence of cardiac beta-myosin heavy chain gene mutations in patients with hypertrophic cardiomyopathy

Genes involved in the regulation of intestinal permeability and their role in ulcerative colitis

Integrins in the Spotlight of Cancer

A real-world analysis of second-line treatment options in pancreatic cancer: liposomal-irinotecan plus 5-fluorouracil and folinic acid

Suchergebnisse filtern